Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Cash Flow PerformanceElevated
Percentile Rank100
Studio
Year-over-Year Change

Free cash flow yield

Latest
1.42%
↑ 117% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthElevated
Average
-8.26%
Historical baseline
PeriodValueYoY Change
20251.42%+163.7%
2024-2.23%+73.4%
2023-8.38%+10.7%
2022-9.39%+33.6%
2021-14.14%-266.3%
2020-3.86%+65.5%
2019-11.17%+38.9%
2018-18.29%-191.5%
2017-6.27%+38.8%
2016-10.24%-